Skip to main content
Year archive

PCI Biotech Holding — 2020 filings

All 44 regulatory filings released by PCI Biotech Holding (PCIB) in 2020, sourced directly from the official regulator.

44 Filings
2020 Period
2020 filings (44)
Filing Released Lang
PCI Biotech: Successful Phase I fimaVacc vaccination proof of concept study to be published in Frontiers in Immunology
Environmental & Social Information
2020-11-23 English
PCI Biotech: European patent for treatment of bile duct cancer with the fimaChem technology
Regulatory Filings
2020-11-16 English
PCI Biotech third quarter 2020 results
Investor Presentation
2020-11-11 English
PCI Biotech third quarter 2020 results
Interim / Quarterly Report Q3 2020
2020-11-11 English
PCI Biotech third quarter 2020 results
Earnings Release Q3 2020
2020-11-11 English
PCI Biotech: Invitation to third quarter 2020 results presentation
Report Publication Announcement
2020-11-04 English
PCI Biotech: First patient enrolled in Asia in the fimaCHEM pivotal RELEASE study
Regulatory Filings
2020-10-26 English
PCI Biotech: Preclinical research collaboration with big pharma ended
Regulatory Filings
2020-10-21 English
PCI Biotech: Employee share option scheme
Remuneration Information
2020-10-06 English
PCI Biotech: Capital increase registered and listing of new shares
Share Issue/Capital Change
2020-09-08 English
Financial calendar
Report Publication Announcement
2020-09-03 English
PCI Biotech: Exercise of employee share options, mandatory notification of trade and resolution to increase share capital
Share Issue/Capital Change
2020-09-02 English
PCI Biotech announce a research collaboration with DCprime to explore novel cancer vaccination concepts
Regulatory Filings
2020-09-01 English
PCI Biotech announce a research collaboration with DCprime to explore novel cancer vaccination concepts
Regulatory Filings
2020-09-01 English
PCI Biotech: First half-year 2020 results
Investor Presentation
2020-08-26 English
PCI Biotech: First half-year 2020 results
Interim / Quarterly Report H1 2020
2020-08-26 English
PCI Biotech: First half-year 2020 results
Report Publication Announcement H1 2020
2020-08-26 English
PCI Biotech: Invitation to second quarter and first half 2020 results presentation
Report Publication Announcement
2020-08-19 English
PCI Biotech: Publication of case report series from the Phase I study in bile duct cancer
Regulatory Filings
2020-08-19 English
PCI Biotech: Update on the preclinical research collaboration agreement with AstraZeneca
Regulatory Filings
2020-07-13 English
MATCHING HALT ENDS
Regulatory Filings
2020-06-22 English
OSLO BØRS - MATCHING HALT
Regulatory Filings
2020-06-22 English
PCI Biotech: Minutes from Annual General Meeting 2020
AGM Information
2020-05-27 Norwegian
PCI Biotech: Minutes from Annual General Meeting 2020
AGM Information
2020-05-27 English
PCI Biotech: Disclosure of voting rights for Chairman of the Board
Declaration of Voting Results & Voting Rights Announcements
2020-05-26 English
PCI Biotech: Notice of Annual General Meeting 2020
Board/Management Information
2020-05-06 Norwegian
PCI Biotech: Notice of Annual General Meeting 2020
Remuneration Information
2020-05-06 English
PCI Biotech: Notice of Annual General Meeting 2020
AGM Information
2020-05-06 English
PCI Biotech: Notice of Annual General Meeting 2020
AGM Information
2020-05-06 English
PCI Biotech: First quarter 2020 results
Investor Presentation
2020-05-06 English
PCI Biotech: First quarter 2020 results
Interim / Quarterly Report Q1 2020
2020-05-06 English
PCI Biotech: First quarter 2020 results
Earnings Release Q1 2020
2020-05-06 English
PCI Biotech appoints Mr Ludovic Robin as Chief Business Officer
Board/Management Information
2020-04-30 English
PCI Biotech: Invitation to Q1 2020 results presentation
Report Publication Announcement
2020-04-28 English
PCI Biotech Holding ASA publishes the Annual Report 2019
Annual Report FY 2019
2020-04-22 English
PCI Biotech Holding ASA publishes the Annual Report 2019
Report Publication Announcement
2020-04-22 English
PCI Biotech appoints Dr Amir Snapir as Chief Medical Officer
Board/Management Information
2020-03-31 English
PCI Biotech: US patent for the vaccine technology (fimaVacc) with a new important class of adjuvants
Regulatory Filings
2020-03-26 English
PCI Biotech: Update on operational implications of the corona pandemic
Regulatory Filings
2020-03-25 English
PCI Biotech's fourth quarter and preliminary 2019 results
Earnings Release Q4 2019
2020-02-26 English
PCI Biotech's fourth quarter and preliminary 2019 results
Investor Presentation
2020-02-26 English
PCI Biotech's fourth quarter and preliminary 2019 results
Report Publication Announcement Q4 2019
2020-02-26 English
PCI Biotech: Invitation to fourth quarter and preliminary 2019 results presentation
Report Publication Announcement
2020-02-19 English
PCI Biotech: US patent granted for the vaccine technology (fimaVacc) in combination with cytokines
Regulatory Filings
2020-01-21 English